Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 26

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats

Roy, Brian D, Bourgeois, Jacqueline M, Mahoney, Douglas J, Tarnopolsky, Mark A·2002·Canadian Journal of Physiology and Pharmacology
DOI 10.1139/y02-129
Open this paper in CoChat — free account

Abstract

Corticosteroids are used as chemotherapeutic agents in many medical conditions, despite many common and potentially serious side effects. Supplementation with creatine monohydrate (CrM) can increase strength and lean body mass in humans and, therefore, may be a viable countermeasure to the side effects of corticosteroids. Therefore, the purpose of this study was to determine if CrM could prevent the attenuation of growth associated with corticosteroid administration. Forty male Sprague–Dawley rats were randomized to the following groups: control (CON, n = 10), 7 mg methylprednisolone·kg–1·week–1 (PRED, n = 10), 2% CrM in diet (CD, n = 10), or CrM and methylprednisolone (CD-PRED, n = 10). Animals received either a weekly sham injection (saline; CON and CD) or an injection of methylprednisolone (PRED and CD-PRED) for 6 weeks. At the completion of the 6th week, body composition was determined and skeletal muscles were collected. Weight gain was attenuated in PRED as compared with all other groups (P < 0.05). Muscle total creatine and phosphocreatine were greater in the extensor digitorum longus in the CD and CD-PRED groups as compared with the CON and PRED groups (P < 0.05); however, total creatine and phosphocreatine in the soleus were not different. Mean fiber area was greater in type II fibers from the extensor digitorum longus in the CD and CD-PRED groups as compared with the CON and PRED groups (P < 0.05); no treatment effect was seen in the soleus. In conclusion, CrM supplementation prevented the attenuation of growth associated with corticosteroids and also increased type II muscle fiber area. These results could have important clinical implications for several patient populations commonly treated with corticosteroids, and further work is required to determine the specific mechanisms underlying the physiological effects that were observed. Key words: nutritional supplement, steroid myopathy, muscle atrophy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1139/y02-129

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 44

  1. Allen D.B., 2002, Pediatr. Pulmonol., 33, 208, 10.1002/ppul.10040 · DOI
  2. Allen D.B., 1994, J. Allergy Clin. Immunol., 93, 967, 10.1016/S0091-6749(94)70043-5 · DOI · Paper page
  3. Almon R.R., 1990, Med. Sci. Sports Exercise, 22, 304, 10.1249/00005768-199006000-00006 · DOI
  4. Anderson J.E., 1996, Muscle Nerve, 19, 1576, 10.1002/(SICI)1097-4598(199612)19:12<1576::AID-MUS7>3.0.CO;2-7 · DOI
  5. Anderson J.E., 2000, Cell Transplant., 9, 551, 10.1177/096368970000900411 · DOI
  6. Auclair D., 1997, Am. J. Physiol., 272, C1007, 10.1152/ajpcell.1997.272.3.C1007 · DOI
  7. Avioli L.V., 1993, Br. J. Rheumatol., 32, 27, 10.1093/rheumatology/32.suppl_2.27 · DOI
  8. Brannon T.A., 1997, Med. Sci. Sports Exercise, 29, 489, 10.1097/00005768-199704000-00010 · DOI
  9. Brooke M.H., 1970, Arch. Neurol., 23, 369, 10.1001/archneur.1970.00480280083010 · DOI · Paper page
  10. Carter S.L., 2001, Can. J. Physiol. Pharmacol., 79, 386, 10.1139/y01-008 · DOI
  11. Casey A., 1996, Am. J. Physiol., 271, E31
  12. Clark A.F., 1979, Muscle Nerve, 2, 265, 10.1002/mus.880020405 · DOI
  13. Ferguson G.T., 1990, Am. Rev. Respir. Dis., 142, 1047, 10.1164/ajrccm/142.5.1047 · DOI
  14. Gardiner P.F., 1979, Muscle Nerve, 2, 274, 10.1002/mus.880020406 · DOI
  15. Gordon A., 1995, Cardiovasc. Res., 30, 413, 10.1016/S0008-6363(95)00062-3 · DOI
  16. Hasselgren P.O., 1999, Curr. Opin. Clin. Nutr. Metab. Care, 2, 201, 10.1097/00075197-199905000-00002 · DOI · Paper page
  17. Hickson R.C., 1997, Proc. Soc. Exp. Biol. Med., 216, 65, 10.3181/00379727-216-44157 · DOI
  18. Juhn M.S., 1998, Clin. J. Sport Med., 8, 286, 10.1097/00042752-199810000-00006 · DOI
  19. Juhn M.S., 1998, Clin. J. Sport Med., 8, 298, 10.1097/00042752-199810000-00007 · DOI
  20. Klivenyi P., 1999, Nat. Med., 5, 347, 10.1038/6568 · DOI · Paper page
  21. Kokontis L., 2000, Arch. Neurol., 57, 939, 10.1001/archneur.57.7.939 · DOI
  22. Marolda M., 1991, Ital. J. Neurol. Sci., 12, 409, 10.1007/BF02335781 · DOI
  23. Marone J.R., 1994, J. Appl. Physiol., 77, 1685, 10.1152/jappl.1994.77.4.1685 · DOI
  24. Matthews R.T., 1999, Exp. Neurol., 157, 142, 10.1006/exnr.1999.7049 · DOI · Paper page
  25. McKay L.I., 1997, Muscle Nerve, 20, 1318, 10.1002/(SICI)1097-4598(199710)20:10<1318::AID-MUS17>3.0.CO;2-Z · DOI
  26. McMillen J., 2001, J. Appl. Physiol., 90, 62, 10.1152/jappl.2001.90.1.62 · DOI
  27. Mihic S., 2000, Med. Sci. Sports Exerc., 32, 291, 10.1097/00005768-200002000-00007 · DOI · Paper page
  28. Nava S., 1996, Am. J. Respir. Crit. Care Med., 153, 1888, 10.1164/ajrccm.153.6.8665051 · DOI
  29. Passaquin A.C., 1993, J. Neurosci. Res., 35, 363, 10.1002/jnr.490350403 · DOI
  30. Passaquin A.C., 2002, Neuromuscul. Disord., 12, 174, 10.1016/S0960-8966(01)00273-5 · DOI · Paper page
  31. Reilly J.J., 2001, J. Clin. Endocrinol. Metab., 86, 3742, 10.1210/jcem.86.8.7764 · DOI
  32. Rothstein J.M., 1983, Muscle Nerve, 6, 128, 10.1002/mus.880060208 · DOI
  33. Ruff R.L., 1988, Neurol. Clin., 6, 575, 10.1016/S0733-8619(18)30862-4 · DOI
  34. Ruff R.L., 1982, Am. J. Physiol., 243, E512
  35. Shoji S., 1989, J. Neurol. Sci., 93, 333, 10.1016/0022-510X(89)90203-7 · DOI
  36. Skoner D.P., 2000, Pediatrics, 105, E23, 10.1542/peds.105.2.e23 · DOI · Paper page
  37. Snow R.J., 2001, Mol. Cell. Biochem., 224, 169, 10.1023/A:1011908606819 · DOI
  38. Tarnopolsky M., 1999, Neurology, 52, 854, 10.1212/WNL.52.4.854 · DOI · Paper page
  39. Tarnopolsky M.A., 1999, Muscle Nerve, 22, 1228, 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.0.CO;2-6 · DOI
  40. Tarnopolsky M.A., 1997, Muscle Nerve, 20, 1502, 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C · DOI · Paper page
  41. Tirapegui J.O., 1994, Clin. Sci., 87, 599, 10.1042/cs0870599 · DOI
  42. Tomas F.M., 1984, Biochem. J., 220, 469, 10.1042/bj2200469 · DOI
  43. Wald J.J., 2000, Neurol. Clin., 18, 695, 10.1016/S0733-8619(05)70219-X · DOI
  44. Walter M.C., 2000, Neurology, 54, 1848, 10.1212/WNL.54.9.1848 · DOI · Paper page

Cited by

See all 26

Metadata

Authors
Roy, B. D., Bourgeois, J. M., Mahoney, D. J., & Tarnopolsky, M. A.
Venue
Canadian Journal of Physiology and Pharmacology
Publisher
Canadian Science Publishing
Published
2002-10-01
Volume
80
Issue
10
Pages
1008-1014
ISSN
  • 0008-4212
  • 1205-7541
DOI
10.1139/y02-129
Cited by
26
References
4
Language
en
Licence
www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats. https://app.cochat.ai/papers/10.1139/y02-129
The paper
Roy, B. D., Bourgeois, J. M., Mahoney, D. J., & Tarnopolsky, M. A. (2002). Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/y02-129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.